Aller au contenu principal

Billets de Michelle Dawson

Billet publié sur Twitter/X le 11/04/2014 04:07

Twitter/X Publication avec DOI crossref Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Alexa Pohl, Sarah Cassidy, Bonnie Auyeung, Simon Baron-Cohen (2014). Uncovering steroidopathy in women with autism: a latent class analysis. Molecular Autism, 5(1), 27. Springer Science and Business Media LLC.

Date de publication
2014
Identifiant
10.1186/2040-2392-5-27
Auteurs
Alexa Pohl, Sarah Cassidy, Bonnie Auyeung, Simon Baron-Cohen
Source
Molecular Autism
Détails
5(1), 27
Type de référence
article
Éditeur
Springer Science and Business Media LLC
Source de métadonnées
crossref

Résumé

BACKGROUND: Prenatal exposure to increased androgens has been implicated in both polycystic ovary syndrome (PCOS) and autism spectrum conditions (ASC), suggesting that PCOS may be increased among women with ASC. One study suggested elevated steroidopathic symptoms ('steroidopathy') in women with ASC. As the symptoms are not independent, we conducted a latent class analysis (LCA). The objectives of the current study are: (1) to test if these findings replicate in a larger sample; and (2) to use LCA to uncover affected clusters of women with ASC. METHODS: We tested two groups of women, screened using the Autism Spectrum Quotient - Group 1: n = 415 women with ASC (mean age 36.39 ± 11.98 years); and Group 2: n = 415 controls (mean age 39.96 ± 11.92 years). All participants completed the Testosterone-related Medical Questionnaire online. A multiple-group LCA was used to identify differences in latent class structure between women with ASC and controls. RESULTS: There were significant differences in frequency of steroid-related conditions and symptoms between women with ASC and controls. A two-class semi-constrained model best fit the data. Based on response patterns, we identified the classes as 'Typical' and 'Steroidopathic'. The prevalence of the 'Steroidopathic' class was significantly increased within the ASC group (ΔG (2) = 15, df =1, P = 0.0001). In particular, we confirmed higher frequencies of epilepsy, amenorrhea, dysmenorrhea, severe acne, gender dysphoria, and transsexualism, and differences in sexual preference in women with ASC. CONCLUSIONS: Women with ASC are at increased risk for symptoms and conditions linked to steroids. LCA revealed this steroidopathy despite the apparent underdiagnosis of PCOS.

Auteur·ices de l’étude dans cette référence citée